Prakash Masand, MD

Duke-NUS, Singapore

  • 2Articles
  • 1.1KReads1
  • 2000–2026Active
  • 7Collaborators

1 Read counts for articles published before 2020 may include some non-human traffic.

About

Prakash Masand, MD, has published on the treatment of dementia-related behavioral disturbances, focusing on the use of acetylcholinesterase inhibitors. His work addresses clinical aspects of dementia and neurology. Masand's contributions appeared in Psychiatrist.com in 2000, often collaborating with co-authors Sanjay Gupta and Subhdeep Virk.

Publications

JCP
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
Original Research

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress

September 14, 2026

Adjunctive lumateperone 42 mg significantly improved depression and anxiety symptoms in patients with MDD with inadequate antidepressant response and anxious distress
, , , et al
PCC
Letter to the Editor

Acetylcholinesterase Inhibitors: Treatment of Dementia-Related Behavioral Disturbances

December 1, 2000

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe